Rise of Asian biopharm creates investment targets for Quintiles
Quintiles expects to make more investments in Asia-Pacific partnerships as the local biopharm sector grows.
Quintiles expects to make more investments in Asia-Pacific partnerships as the local biopharm sector grows.
Ranbaxy has introduced generic Lipitor in the US after partnering with Teva and gaining FDA approval for manufacture at its US plant.
The drug industry's need to improve product quality while reducing production costs is driving global demand for testing technologies according to Sepha.
Pharma companies and contract research organisations will soon be able to view important UK health data.
Large volume production is a must for the cell therapy sector according to ATMI, which claims the latest addition to its single-use bioreactor range can help manufacturers overcome the GMP hurdles that hinder commercial scale-up.